Results 31 to 40 of about 1,682 (148)

Effectiveness of transdermal fluralaner in the treatment of Lynxacarus radovskyi (Acari: Listrophoridae) in naturally infested domestic cats. [PDF]

open access: goldRev Bras Parasitol Vet, 2023
Guimarães BMC   +6 more
europepmc   +3 more sources

Open field study on the efficacy of oral fluralaner for long-term control of flea allergy dermatitis in client-owned dogs in Ile-de-France region [PDF]

open access: gold, 2016
BACKGROUND: Fluralaner is the first orally administered isoxazoline to provide 12 weeks of activity against fleas and ticks after a single administration.
Céline Hubinois   +5 more
core   +4 more sources

Acaricidal efficacy of fluralaner against Rhipicephalus microplus ticks under laboratory and field conditions in Brazil. [PDF]

open access: goldParasit Vectors
Rodrigues DC   +13 more
europepmc   +2 more sources

Flea and tick treatment satisfaction, preference, and adherence of U.S. cat owners prescribed topical fluralaner (Bravecto® Topical Solution for Cats) [PDF]

open access: yesOpen Veterinary Journal, 2021
Background: Fluralaner is a novel isoxazoline compound and the only systemically distributed ectoparasiticide approved in the United States for re-dosing at up to 12-week intervals for flea and tick control in cats.
Robert Lavan   +3 more
doaj   +1 more source

Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the U.S., U.K., or France who treated their cats with transdermal fluralaner [PDF]

open access: yesOpen Veterinary Journal, 2021
Background: Fluralaner (Bravecto®) is an isoxazoline class compound that is the only topically applied systemic ectoparasiticide approved for dosing at up to 12-week intervals for flea and tick control in cats.
Robert Philip Lavan   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy